These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2939383)

  • 1. Functional activities of enriched Fc receptor bearing T lymphocytes in Hodgkin's disease.
    Gulwani BN; Advani SH; Gangal SG
    Oncology; 1986; 43(3):159-64. PubMed ID: 2939383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of subpopulations of T lymphocytes in Hodgkin's disease.
    Gulwani BN; Advani SH; Gangal SG
    Neoplasma; 1985; 32(2):239-46. PubMed ID: 3873623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
    Begemann M; Claas G; Falke H
    Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential.
    Mukhopadhyaya R; Advani SH; Gangal SG
    Acta Haematol; 1983; 70(6):357-63. PubMed ID: 6417959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell subsets in peripheral blood of patients with newly diagnosed and posttreatment Hodgkin's and non-Hodgkin's lymphomas. Analysis by monoclonal antibody staining and flow cytometry.
    De Angelis P; Kimmel M; Lacher M; Filippa D; Melamed MR
    Anal Quant Cytol Histol; 1988 Aug; 10(4):235-42. PubMed ID: 2971365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment in cellular protein phosphorylation by mitogen activated lymphocytes from patients with Hodgkin's disease.
    Damle RN; Gangal SG; Advani SH
    Indian J Med Res; 1992 Aug; 96():230-5. PubMed ID: 1428061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
    Damle RN; Advani SH; Gangal SG
    Cancer Immunol Immunother; 1991; 34(3):205-10. PubMed ID: 1756538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
    Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
    Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished autologous mixed lymphocyte reaction in patients with Hodgkin disease: evidence for non-T cell dysfunction.
    Zamkoff KW; Dock NL; Kurec AS; Davey FR
    Am J Hematol; 1982 Jun; 12(4):327-35. PubMed ID: 6214184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
    Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte subpopulations defined by monoclonal antibodies and FC receptor binding in relation to immunosuppression in vaccine-induced rubella infection.
    Arneborn P; Biberfeld G; von Stedingk LV
    Acta Pathol Microbiol Immunol Scand C; 1982 Jun; 90(3):163-70. PubMed ID: 6214140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
    Engleman EG; Benike C; Hoppe RT; Kaplan HS
    Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic profile in patients with Hodgkin's disease in complete remission.
    Liberati AM; Ballatori E; Fizzotti M; Schippa M; Proietti MG; Di Marzio R; Pecci A; Biscetti L; Sbarretti R; Cini L
    Cancer; 1987 Jun; 59(11):1906-13. PubMed ID: 3105863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.